{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T06:16:51Z","timestamp":1781590611038,"version":"3.54.5"},"reference-count":16,"publisher":"American Academy of Pediatrics (AAP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:sec>\n                  <jats:title>BACKGROUND<\/jats:title>\n                  <jats:p>Viral testing and treatments such as systemic steroids and inhaled corticosteroids are low-value care for routine bronchiolitis. We sought to determine the impact of the COVID-19 pandemic on low-value care in young children with bronchiolitis.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>METHODS<\/jats:title>\n                  <jats:p>This was a retrospective, cross-sectional study using the Pediatric Health Information Systems database. We included children &amp;lt;2 years seen in a pediatric emergency department for bronchiolitis. We selected a priori 3 study periods: September 2018 to February 2020 (prepandemic), March 2020 to August 2022 (early pandemic), and September 2022 to January 2023 (late pandemic). Low-value care included respiratory syncytial virus testing, chest radiography, albuterol, or corticosteroids and was compared across the 3 time periods.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>At least 1 element of low-value care was provided in 45%, 47%, and 44% of encounters in the prepandemic, early pandemic, and late pandemic periods, respectively. There was little variation in the use of albuterol and chest radiography across time periods and a slight increase in systemic corticosteroid use from prepandemic to early and late pandemic groups. Viral testing increased from 36% prepandemic to 65% early pandemic and 67% late pandemic, which appeared to be driven by SARS-CoV-2 testing and combination viral testing.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>There was no clinically significant change in low-value care for bronchiolitis during the pandemic. Because of SARS-CoV-2 testing, however, overall frequency of viral testing increased dramatically over time. This marked increase in overall viral testing should be taken into consideration for future quality improvement efforts.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1542\/hpeds.2024-007751","type":"journal-article","created":{"date-parts":[[2024,6,14]],"date-time":"2024-06-14T08:08:11Z","timestamp":1718352491000},"page":"e299-e303","source":"Crossref","is-referenced-by-count":4,"title":["Impact of the COVID-19 Pandemic on Low-Value Testing and Treatment of Bronchiolitis"],"prefix":"10.1542","volume":"14","author":[{"given":"Emily J.","family":"Labudde","sequence":"first","affiliation":[{"name":"aPediatric Residency Program"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick S.","family":"Walsh","sequence":"additional","affiliation":[{"name":"bDepartment of Pediatrics, Section of Pediatric Emergency Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew J.","family":"Lipshaw","sequence":"additional","affiliation":[{"name":"cDivision of Emergency Medicine, Cincinnati Children\u2019s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Kerrey","sequence":"additional","affiliation":[{"name":"cDivision of Emergency Medicine, Cincinnati Children\u2019s Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2024,6,14]]},"reference":[{"issue":"5","key":"2024070102503988800_B1","doi-asserted-by":"crossref","first-page":"e1474","DOI":"10.1542\/peds.2014-2742","article-title":"Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis","volume":"134","author":"Ralston","year":"2014","journal-title":"Pediatrics"},{"issue":"4","key":"2024070102503988800_B2","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1056\/NEJMoa071255","article-title":"A multicenter, randomized, controlled trial of dexamethasone for bronchiolitis","volume":"357","author":"Corneli","year":"2007","journal-title":"N Engl J Med"},{"issue":"6","key":"2024070102503988800_B3","first-page":"CD001266","article-title":"Bronchodilators for bronchiolitis","volume":"2014","author":"Gadomski","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2024070102503988800_B4","doi-asserted-by":"crossref","first-page":"e2037356","DOI":"10.1001\/jamanetworkopen.2020.37356","article-title":"Trends over time in use of nonrecommended tests and treatments since publication of the American Academy of Pediatrics bronchiolitis guideline","volume":"4","author":"House","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2024070102503988800_B5","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1093\/pch\/pxaa013","article-title":"Adherence to national paediatric bronchiolitis management guidelines and impact on emergency department resource utilization","volume":"26","author":"Maki","year":"2020","journal-title":"Paediatr Child Health"},{"issue":"2","key":"2024070102503988800_B6","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0301-0546(09)71106-1","article-title":"Single oral dose of dexamethasone in outpatients with bronchiolitis: a placebo controlled trial","volume":"37","author":"Mesquita","year":"2009","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"2","key":"2024070102503988800_B7","doi-asserted-by":"crossref","first-page":"e210157","DOI":"10.1001\/jamanetworkopen.2021.0157","article-title":"Improving value in bronchiolitis care","volume":"4","author":"Schroeder","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2024070102503988800_B8","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1002\/ppul.26640","article-title":"The changing virology and trends in resource utilization for bronchiolitis since COVID-19","volume":"58","author":"Burks","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"11","key":"2024070102503988800_B9","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1007\/s00431-022-04601-w","article-title":"Increased use of high-flow nasal cannulas after the pandemic in bronchiolitis: a more severe disease or a changed physician\u2019s attitude?","volume":"181","author":"Ghirardo","year":"2022","journal-title":"Eur J Pediatr"},{"issue":"7","key":"2024070102503988800_B10","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1002\/ppul.26434","article-title":"Pediatric respiratory admissions and related viral infections during the COVID-19 pandemic","volume":"58","author":"Moscovich","year":"2023","journal-title":"Pediatr Pulmonol"},{"issue":"10","key":"2024070102503988800_B11","doi-asserted-by":"crossref","first-page":"e2339884","DOI":"10.1001\/jamanetworkopen.2023.39884","article-title":"Admissions for bronchiolitis at Children\u2019s Hospitals before and during the COVID-19 pandemic","volume":"6","author":"Remien","year":"2023","journal-title":"JAMA Netw Open"},{"key":"2024070102503988800_B12","doi-asserted-by":"crossref","first-page":"o2681","DOI":"10.1136\/bmj.o2681","article-title":"US faces triple epidemic of flu, RSV, and covid","volume":"379","author":"Tanne","year":"2022","journal-title":"BMJ"},{"issue":"8","key":"2024070102503988800_B13","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1097\/INF.0000000000003576","article-title":"An approach to the treatment of children with COVID-19","volume":"41","author":"Boast","year":"2022","journal-title":"Pediatr Infect Dis J"},{"key":"2024070102503988800_B14","author":"PHIS"},{"issue":"2","key":"2024070102503988800_B15","doi-asserted-by":"crossref","first-page":"e2022058389","DOI":"10.1542\/peds.2022-058389","article-title":"Pediatric respiratory illnesses: an update on achievable benchmarks of care","volume":"152","author":"Reyes","year":"2023","journal-title":"Pediatrics"},{"key":"2024070102503988800_B16","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/1471-2431-14-199","article-title":"Pediatric complex chronic conditions classification system version 2: updated for ICD-10 and complex medical technology dependence and transplantation","volume":"14","author":"Feudtner","year":"2014","journal-title":"BMC Pediatr"}],"container-title":["Hospital Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/7\/e299\/1671626\/hpeds.2024-007751.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article-pdf\/14\/7\/e299\/1671626\/hpeds.2024-007751.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T02:50:53Z","timestamp":1719802253000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/hospitalpediatrics\/article\/14\/7\/e299\/197495\/Impact-of-the-COVID-19-Pandemic-on-Low-Value"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,14]]},"references-count":16,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,6,14]]},"published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1542\/hpeds.2024-007751","relation":{},"ISSN":["2154-1663","2154-1671"],"issn-type":[{"value":"2154-1663","type":"print"},{"value":"2154-1671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,14]]}}}